{
    "eid": "2-s2.0-85167844401",
    "title": "Recent evidence of economic evaluation of artificial intelligence in ophthalmology",
    "cover-date": "2023-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Ophthalmology",
            "@code": "2731",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "artificial intelligence",
        "economic evaluation",
        "health technology assessment",
        "public health"
    ],
    "authors": [
        "Paisan Ruamviboonsuk",
        "Varis Ruamviboonsuk",
        "Richa Tiwari"
    ],
    "citedby-count": 0,
    "ref-count": 58,
    "ref-list": [
        "When should global health actors prioritise more uncertain interventions?",
        "Health economic evaluation: Important principles and methodology",
        "Major concepts of healthcare economics",
        "Artificial intelligence in healthcare",
        "Comprehensive review on the use of artificial intelligence in ophthalmology and future research directions",
        "Systematic review of health economic evaluations focused on artificial intelligence in healthcare: The tortoise and the cheetah",
        "Economic evaluations of artificial intelligence in ophthalmology",
        "Economic evaluation for ophthalmologists",
        "The value of artificial intelligence for healthcare decision making-lessons learned",
        "Economics notes: Opportunity cost",
        "Economics notes: Perspectives in economic evaluation",
        "Marginal costs and benefits",
        "An introduction to Markov modelling for economic evaluation",
        "Principles of cost analysis",
        "Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: An economic analysis modelling study",
        "Cost-benefit analysis",
        "A cost-benefit analysis of VEGF-inhibitor therapy for neovascular age-related macular degeneration in the United States",
        "Cost-effectiveness analysis",
        "Automated diabetic retinopathy image assessment software: Diagnostic accuracy and cost-effectiveness compared with human graders",
        "Cost-utility analysis",
        "Cost-utility analysis of deep learning and trained human graders for diabetic retinopathy screening in a nationwide program",
        "Assessing the economic value of clinical artificial intelligence: Challenges and opportunities",
        "Innovation in the pharmaceutical industry: New estimates of R&D costs",
        "Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland",
        "Five-year cost-effectiveness modeling of primary care-based, nonmydriatic automated retinal image analysis screening among low-income patients with diabetes",
        "Cost-effectiveness of autonomous point-of-care diabetic retinopathy screening for pediatric patients with diabetes",
        "Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China",
        "Cost-effectiveness of artificial intelligence as a decision-support system applied to the detection and grading of melanoma, dental caries, and diabetic retinopathy",
        "Cost-effectiveness of artificial intelligence-based retinopathy of prematurity screening",
        "Diabetic retinopathy screening with automated retinal image analysis in a primary care setting improves adherence to ophthalmic care",
        "Real-world effectiveness of screening programs for age-related macular degeneration: Amended Japanese specific health checkups and augmented screening programs with OCT or AI",
        "Healthcare cost and benefits of artificial intelligence-Assisted population-based glaucoma screening for the elderly in remote areas of China: A cost-offset analysis",
        "Agreement among glaucoma specialists in assessing progressive disc changes from photographs in open-Angle glaucoma patients",
        "Towards better patient outcomes -The cost-offset model",
        "Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks",
        "Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity",
        "Automated identification of retinopathy of prematurity by image-based deep learning",
        "Deep learning algorithm for automated diagnosis of retinopathy of prematurity plus disease",
        "Assessing the value of artificial intelligence in retinopathy of prematurity screening: Be specific with regard to the data",
        "The neovascular age-related macular degeneration database: Report 2: Incidence, management, and visual outcomes of second treated eyes",
        "Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: The Beaver Dam Eye Study",
        "Vision and quality-of-life",
        "Neovascular age-related macular degeneration: Is it worthwhile treating an eye with poor visual acuity, if the visual acuity of the fellow eye is good?",
        "The clinical effectiveness and cost-effectiveness of screening for age-related macular degeneration in Japan: A Markov modeling study. Chiu CJ, editor",
        "Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration",
        "Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: A systematic review",
        "Application of artificial intelligence in cataract management: Current and future directions",
        "Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study",
        "Deep learning in optical coherence tomography angiography: Current progress, challenges, and future directions",
        "Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning",
        "Validation of an automated artificial intelligence algorithm for the quantification of major OCT parameters in diabetic macular edema",
        "Evaluation of an artificial intelligence-based detector of sub-And intraretinal fluid on a large set of optical coherence tomography volumes in age-related macular degeneration and diabetic macular edema",
        "Predicting the risk of developing diabetic retinopathy using deep learning",
        "Predicting conversion to wet age-related macular degeneration using deep learning",
        "The potential cost-effectiveness of a machine learning tool that can prevent untimely intensive care unit discharge",
        "A framework for using real-world data and health outcomes modeling to evaluate machine learning-based risk prediction models"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Mountain View",
            "@id": "60006191",
            "affilname": "Google LLC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006191",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}